Skip to main content
← Docket
Money

Briefing: BioNTech Shares Fall After Cofounders Plan Exit, Outlook Misses Forecasts

Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.

Editorial Staff1 min read